Framework Ventures IV L.P.

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Michael Ernest Anderson - Framework Ventures IV L.P. - Authorized Signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Framework Ventures IV L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
NovaBay Pharmaceuticals, Inc. 10%+ Owner Common Stock 56,806,080 $74,228,504 $1.31 21 Oct 2025 Direct
NovaBay Pharmaceuticals, Inc. 10%+ Owner Pre-Funded Warrants (Right to Buy) 2,702,703 16 Oct 2025 Direct
NovaBay Pharmaceuticals, Inc. 10%+ Owner Series D Non-Voting Convertible Preferred Stock 220,663 16 Oct 2025 Direct
NovaBay Pharmaceuticals, Inc. 10%+ Owner Series E Non-Voting Convertible Preferred Stock 134,375 16 Oct 2025 Direct

Insider Reports Filed by Framework Ventures IV L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
NBY NovaBay Pharmaceuticals, Inc. 16 Oct 2025 2 $0 4 10%+ Owner 03 Nov 2025, 21:39
NBY NovaBay Pharmaceuticals, Inc. 16 Oct 2025 2 $0 4/A 10%+ Owner 22 Oct 2025, 21:27
NBY NovaBay Pharmaceuticals, Inc. 09 Oct 2025 0 $0 3/A 10%+ Owner 22 Oct 2025, 21:22